- Home
- JMSB vs RNAC Comparison
JMSB vs RNAC Comparison
Compare JMSB & RNAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JMSB
- RNAC
- Stock Information
- Founded
- JMSB 2005
- RNAC 2007
- Country
- JMSB United States
- RNAC United States
- Employees
- JMSB 133
- RNAC N/A
- Industry
- JMSB Major Banks
- RNAC Biotechnology: Pharmaceutical Preparations
- Sector
- JMSB Finance
- RNAC Health Care
- Exchange
- JMSB Nasdaq
- RNAC Nasdaq
- Market Cap
- JMSB 271.1M
- RNAC 276.3M
- IPO Year
- JMSB N/A
- RNAC 2016
- Fundamental
- Price
- JMSB $19.00
- RNAC $8.26
- Analyst Decision
- JMSB Buy
- RNAC Strong Buy
- Analyst Count
- JMSB 2
- RNAC 4
- Target Price
- JMSB $22.50
- RNAC $40.00
- AVG Volume (30 Days)
- JMSB 15.6K
- RNAC 139.5K
- Earning Date
- JMSB 10-29-2025
- RNAC 11-07-2025
- Dividend Yield
- JMSB 1.56%
- RNAC N/A
- EPS Growth
- JMSB 18.26
- RNAC N/A
- EPS
- JMSB 1.40
- RNAC N/A
- Revenue
- JMSB $59,274,000.00
- RNAC $1,026,000.00
- Revenue This Year
- JMSB $18.55
- RNAC N/A
- Revenue Next Year
- JMSB $13.30
- RNAC N/A
- P/E Ratio
- JMSB $13.32
- RNAC N/A
- Revenue Growth
- JMSB 11.69
- RNAC N/A
- 52 Week Low
- JMSB $13.81
- RNAC $7.75
- 52 Week High
- JMSB $26.52
- RNAC $26.50
- Technical
- Relative Strength Index (RSI)
- JMSB 47.05
- RNAC 35.57
- Support Level
- JMSB $18.50
- RNAC $8.02
- Resistance Level
- JMSB $20.02
- RNAC $9.49
- Average True Range (ATR)
- JMSB 0.55
- RNAC 0.57
- MACD
- JMSB -0.01
- RNAC -0.10
- Stochastic Oscillator
- JMSB 32.89
- RNAC 11.19
About JMSB John Marshall Bancorp Inc.
John Marshall Bancorp Inc is a bank holding company. Through its banking subsidiary, it offers banking products and financial services to small to medium-sized businesses, professional corporations, non-profits, and individuals. The products and services offered by the company include commercial checking, savings, and money market accounts, certificates of deposit, treasury and cash management services, commercial and industrial loans, commercial real estate loans, residential and commercial construction and development loans, online banking, and mobile banking. The firm serves local businesses, professionals, individuals, and families throughout the Washington, D.C. metropolitan area.
About RNAC Cartesian Therapeutics Inc.
Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company. The company uses its ImmTOR immune tolerance platform, which is designed to give rise to antigen-specific immunity, mitigating unwanted immune responses. The company leverages its proprietary technology and manufacturing platform to introduce one or more mRNA molecules into cells to enhance their function.